Best Stocks Under $3 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $3.00 (3 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. Denison Mines NYSEAMERICAN:DNN$1.50 -0.03 (-1.96%) Closing price 03/21/2025 04:10 PM EasternExtended Trading$1.50 0.00 (-0.33%) As of 03/21/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison MinesMarket Capitalization$1.34 billionP/E Ratio-150.00Consensus RatingStrong BuyConsensus Price Target$3.00 (+100.0% Upside)Volume71.94 million sharesAverage Volume24.79 million shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Achieve Life Sciences NASDAQ:ACHV$2.81 +0.06 (+2.18%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$2.90 +0.09 (+3.20%) As of 03/21/2025 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Achieve Life Sciences, Inc, a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. More about Achieve Life SciencesMarket Capitalization$97.47 millionP/E Ratio-2.49Consensus RatingBuyConsensus Price Target$15.75 (+460.5% Upside)Volume207,633 sharesAverage Volume170,817 shares3. Stardust Power NASDAQ:SDST$0.66 -0.01 (-1.48%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$0.67 +0.01 (+1.53%) As of 03/21/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.Market Capitalization$34.84 millionConsensus RatingBuyConsensus Price Target$7.94 (+1,102.8% Upside)Volume237,002 sharesAverage Volume358,147 sharesToday's Range$0.65▼$0.704. Quince Therapeutics NASDAQ:QNCX$1.38 +0.01 (+0.73%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$1.38 0.00 (-0.36%) As of 03/21/2025 05:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince TherapeuticsMarket Capitalization$60.72 millionP/E Ratio-1.11Consensus RatingBuyConsensus Price Target$9.50 (+588.4% Upside)Volume98,446 sharesAverage Volume243,766 shares5. enCore Energy NASDAQ:EU$1.65 -0.01 (-0.60%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$1.62 -0.02 (-1.52%) As of 03/21/2025 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. More about enCore EnergyMarket Capitalization$307.33 millionP/E Ratio-5.89Consensus RatingBuyConsensus Price Target$4.38 (+165.2% Upside)Volume2.60 million sharesAverage Volume1.39 million shares6. Rezolve AI NASDAQ:RZLV$1.65 +0.13 (+8.55%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$1.62 -0.02 (-1.52%) As of 03/21/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rezolve Ai Ltd. operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AIMarket Capitalization$284.10 millionConsensus RatingBuyConsensus Price Target$6.40 (+287.9% Upside)Volume2.02 million sharesAverage Volume5.33 million sharesToday's Range$1.44▼$1.66Remove Ads7. Nkarta NASDAQ:NKTX$1.50 0.00 (0.00%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$1.46 -0.04 (-2.60%) As of 03/21/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about NkartaMarket Capitalization$105.85 millionP/E Ratio-0.80Consensus RatingBuyConsensus Price Target$15.00 (+900.0% Upside)Volume911,036 sharesAverage Volume990,599 shares8. GeoVax Labs NASDAQ:GOVX$1.31 -0.04 (-2.96%) As of 03/21/2025 04:00 PM EasternGeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax LabsMarket Capitalization$12.36 millionConsensus RatingBuyConsensus Price Target$14.20 (+984.0% Upside)Volume489,116 sharesAverage Volume638,654 sharesToday's Range$1.25▼$1.369. Mereo BioPharma Group NASDAQ:MREO$2.38 -0.18 (-7.03%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$2.38 +0.00 (+0.21%) As of 03/21/2025 06:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma GroupMarket Capitalization$369.25 millionConsensus RatingBuyConsensus Price Target$7.83 (+229.1% Upside)Volume1.04 million sharesAverage Volume1.00 million sharesToday's Range$2.38▼$2.5710. Reviva Pharmaceuticals NASDAQ:RVPH$1.04 -0.06 (-5.45%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$1.05 +0.01 (+0.96%) As of 03/21/2025 07:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva PharmaceuticalsMarket Capitalization$34.78 millionP/E Ratio-0.94Consensus RatingBuyConsensus Price Target$11.40 (+996.2% Upside)Volume1.16 million sharesAverage Volume1.08 million shares11. Cardiol Therapeutics NASDAQ:CRDL$1.12 -0.07 (-5.88%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$1.12 +0.00 (+0.45%) As of 03/21/2025 06:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol TherapeuticsMarket Capitalization$92.52 millionP/E Ratio-2.87Consensus RatingBuyConsensus Price Target$8.40 (+650.0% Upside)Volume72,789 sharesAverage Volume390,428 sharesRemove Ads12. Immunic NASDAQ:IMUX$1.15 +0.01 (+0.88%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$1.16 +0.01 (+0.43%) As of 03/21/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about ImmunicMarket Capitalization$103.59 millionP/E Ratio-0.93Consensus RatingBuyConsensus Price Target$12.67 (+1,001.4% Upside)Volume264,060 sharesAverage Volume595,058 shares13. Western Copper & Gold NYSE:WRN$1.13 -0.02 (-1.74%) As of 03/21/2025 04:00 PM EasternWestern Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & GoldMarket Capitalization$224.23 millionP/E Ratio-56.50Consensus RatingBuyConsensus Price Target$4.25 (+276.1% Upside)Volume174,917 sharesAverage Volume304,998 shares14. HIVE Digital Technologies NASDAQ:HIVE$1.66 -0.01 (-0.60%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$1.66 0.00 (-0.30%) As of 03/21/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.HIVE Digital Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. The company engages in the mining and sale of digital currencies, including Ethereum Classic, Bitcoin, and other coins. More about HIVE Digital TechnologiesMarket Capitalization$262.43 millionP/E Ratio-33.20Consensus RatingBuyConsensus Price Target$7.64 (+360.4% Upside)Volume14.43 million sharesAverage Volume5.64 million shares15. Lucid Diagnostics NASDAQ:LUCD$1.52 -0.05 (-3.18%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$1.52 0.00 (0.00%) As of 03/21/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid DiagnosticsMarket Capitalization$90.20 millionP/E Ratio-1.33Consensus RatingBuyConsensus Price Target$3.63 (+138.5% Upside)Volume1.08 million sharesAverage Volume352,295 shares16. Electrovaya NASDAQ:ELVA$2.76 -0.09 (-3.16%) Closing price 03/21/2025 03:59 PM EasternExtended Trading$2.77 +0.01 (+0.36%) As of 03/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Electrovaya Inc engages in the design, development, manufacture, and sale of lithium-ion batteries, battery management systems, and battery-related products for energy storage, clean electric transportation, and other specialized applications in North America. More about ElectrovayaMarket Capitalization$110.70 millionP/E Ratio-69.00Consensus RatingBuyConsensus Price Target$6.10 (+121.0% Upside)Volume83,799 sharesAverage Volume50,453 sharesRemove Ads17. Ceragon Networks NASDAQ:CRNT$2.53 +0.02 (+0.80%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$2.57 +0.04 (+1.58%) As of 03/21/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ceragon Networks Ltd., together with its subsidiaries, provides wireless transport solutions for cellular operators and other wireless service providers in North America, Europe, Africa, the Asia Pacific, the Middle East, India, and Latin America. More about Ceragon NetworksMarket Capitalization$216.11 millionP/E Ratio9.37Consensus RatingBuyConsensus Price Target$6.38 (+152.0% Upside)Volume592,725 sharesAverage Volume994,140 shares18. Invivyd NASDAQ:IVVD$0.74 0.00 (-0.08%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$0.74 +0.01 (+0.81%) As of 03/21/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Invivyd, Inc, a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. More about InvivydMarket Capitalization$88.28 millionP/E Ratio-0.38Consensus RatingBuyConsensus Price Target$7.89 (+968.8% Upside)Volume2.78 million sharesAverage Volume4.24 million shares19. PMV Pharmaceuticals NASDAQ:PMVP$1.27 +0.01 (+0.79%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$1.27 0.00 (0.00%) As of 03/21/2025 05:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.PMV Pharmaceuticals, Inc, a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. More about PMV PharmaceuticalsMarket Capitalization$65.96 millionP/E Ratio-1.27Consensus RatingBuyConsensus Price Target$5.50 (+333.1% Upside)Volume51,786 sharesAverage Volume285,263 shares20. FibroBiologics NASDAQ:FBLG$1.11 +0.08 (+7.77%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$1.12 +0.01 (+0.99%) As of 03/21/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologicsMarket Capitalization$40.41 millionConsensus RatingBuyConsensus Price Target$13.00 (+1,071.2% Upside)Volume175,738 sharesAverage Volume274,876 sharesToday's Range$1.00▼$1.1521. Lexeo Therapeutics NASDAQ:LXEO$2.71 +0.02 (+0.74%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$2.69 -0.02 (-0.74%) As of 03/21/2025 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lexeo Therapeutics, Inc operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. More about Lexeo TherapeuticsMarket Capitalization$89.61 millionP/E Ratio-0.86Consensus RatingBuyConsensus Price Target$23.80 (+778.2% Upside)Volume513,959 sharesAverage Volume302,087 shares22. Gain Therapeutics NASDAQ:GANX$2.34 +0.05 (+2.18%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$2.35 +0.01 (+0.21%) As of 03/21/2025 04:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Gain Therapeutics, Inc, a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. More about Gain TherapeuticsMarket Capitalization$62.07 millionP/E Ratio-2.13Consensus RatingBuyConsensus Price Target$8.20 (+250.4% Upside)Volume126,185 sharesAverage Volume280,205 shares23. Rani Therapeutics NASDAQ:RANI$1.55 +0.05 (+3.33%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$1.50 -0.05 (-3.23%) As of 03/21/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rani Therapeutics Holdings, Inc operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. More about Rani TherapeuticsMarket Capitalization$88.80 millionP/E Ratio-1.46Consensus RatingBuyConsensus Price Target$12.33 (+695.7% Upside)Volume81,401 sharesAverage Volume748,845 shares24. ProQR Therapeutics NASDAQ:PRQR$1.65 +0.02 (+1.23%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$1.64 0.00 (-0.30%) As of 03/21/2025 04:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ProQR Therapeutics N.V., a biotechnology company, focuses on the discovery and development of novel therapeutic medicines. More about ProQR TherapeuticsMarket Capitalization$134.77 millionP/E Ratio-5.16Consensus RatingBuyConsensus Price Target$9.50 (+475.8% Upside)Volume629,073 sharesAverage Volume550,770 shares25. Perspective Therapeutics NYSE:CATX$2.52 +0.03 (+1.20%) Closing price 03/21/2025 04:00 PM EasternExtended Trading$2.52 0.00 (-0.20%) As of 03/21/2025 06:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective TherapeuticsMarket Capitalization$170.32 millionConsensus RatingBuyConsensus Price Target$14.56 (+477.6% Upside)Volume933,336 sharesAverage Volume990,696 sharesToday's Range$2.38▼$2.59 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 03/17 - 03/21 FedEx Delivers Another Crushing Blow to Its Stock Price Micron Stock Will Retest All-Time Highs This Year Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge Could Palantir’s R1 Deal Be the Catalyst for a Stock Surge? BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock? Affirm Stock: Should You Buy the Dip After Walmart Setback? AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
